Pages that link to "Q57308303"

The following pages link to Epidemiology of heart failure with preserved ejection fraction (Q57308303):

Displaying 19 items.

• Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?" (Q26785931) (← links)
• Body mass index and heart failure among patients with type 2 diabetes mellitus (Q36100786) (← links)
• Epidemiology and aetiology of heart failure (Q36905978) (← links)
• Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure (Q37240351) (← links)
• Heart Failure in Women--Insights from the Framingham Heart Study (Q37637447) (← links)
• Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT? (Q38593070) (← links)
• Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function (Q38732534) (← links)
• Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine (Q38764956) (← links)
• Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction (Q41025346) (← links)
• The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition (Q59335403) (← links)
• Association between heart failure with preserved ejection fraction and hypertensive retinopathy: more questions than answers! (Q88377396) (← links)
• What is Heart Failure with Mid-range Ejection Fraction? A New Subgroup of Patients with Heart Failure (Q89071673) (← links)
• Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy (Q90178740) (← links)
• Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults (Q90219054) (← links)
• Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure (Q90331231) (← links)
• Sex Differences in the Cardiac Effects of Early-Onset Hypertension (Q90349744) (← links)
• Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction (Q91644952) (← links)
• Clinical Course after a First Episode of Heart Failure: Insights from the Framingham Heart Study (Q95938141) (← links)
• Metabolomic signatures of cardiac remodelling and heart failure risk in the community (Q99252421) (← links)